Mesalamine, also known as 5-aminosalicylic acid (5-ASA), is a medication used to treat ulcerative colitis. It is usually used to induce or maintain remission of mildly to moderately active ulcerative colitis. Clinicians may use mesalamine off-labeled in Crohn disease after surgical resection of the affected bowel. It is under the drug classification of aminosalicylates. This activity reviews the indications, mechanisms of action, contraindications, adverse effects, administration options, and other key factors of mesalamine. This activity will also highlight the relevant aspects for healthcare professionals in managing patients with ulcerative colitis and related conditions when administering mesalamine.

**Objectives:**
- Identify the mechanism of action of mesalamine.
- Describe the adverse effects of mesalamine.
- Review appropriate monitoring parameters for the administration of mesalamine.
- Summarize interprofessional team strategies for improving care coordination and communication to advance mesalamine and improve outcomes.